Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Intra-Cellular Therapies(ITCI) Newsfilter·2024-04-25 04:01公开发行详情 - Intra-Cellular Therapies完成了公开发行1,027,397股普通股，募集资金约为575百万美元[1] - J.P. Morgan, Leerink Partners, BofA Securities, Morgan Stanley和RBC Capital Markets担任了此次发行的联席主承销商[3] - 公开发行是根据之前向证券交易委员会（SEC）提交的Form S-3注册声明进行的[4]